ArticleWorld journal of otorhinolaryngology - head and neck surgery2026
Endoscopic Total Thyroidectomy via a Single-Port Subclavian Approach Versus Open Surgery for Papillary Thyroid Carcinoma.
Article in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Endoscopic Total Thyroidectomy via a Single-Port Subclavian Approach Versus Open Surgery for Papillary Thyroid Carcinoma.World journal of otorhinolaryngology - head and neck surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Historically, performing contralateral thyroid lobectomy and lymph node dissection via the subclavian approach has been considered challenging. This study evaluated the safety and feasibility of gasless endoscopic total thyroidectomy and central compartment neck dissection via the single-port subclavian approach (SpSCA) in comparison with conventional open surgery for the treatment of papillary thyroid carcinoma (PTC). Methods: Between January 2019 and June 2023, 120 patients diagnosed with PTC were retrospectively enrolled into this study, with 26 undergoing the SpSCA procedure and 94 receiving conventional surgery. Propensity score full matching was used to balance baseline characteristics between the groups. Subsequently, weighted regression analyses (adjusted for age) were used to compare perioperative outcomes, complications, survival, and esthetic results between the groups. Results: After matching, the SpSCA procedure was associated with a significantly longer operative time than open surgery (adjusted difference: 37.3 min, 95% confidence interval [CI]: 16.5-58.2). However, no significant differences were noted in postoperative hospital stay, bleeding volume, drainage volume, or major complications between the groups. During the median follow-up period of 34-36 months, biologic events occurred in six patients who underwent open surgery and one patient who underwent SpSCA; no structural events were observed. Disease-free survival curves were similar between the groups. The SpSCA group exhibited significantly higher esthetic satisfaction scores (adjusted difference: 2.26, 95% CI: 1.56-2.96). Conclusion: The SpSCA approach is a safe and feasible alternative to conventional surgery for selected patients with PTC, offering superior esthetic results and comparable clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.